ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Orthopaedic Surgery

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,735Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 397

$1.11M Total Retail Price of All Prescriptions

Rank: 2 out of 397

593 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

72% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 27%.

Schedule Three
Controlled Substances

22% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 41%.

Risky Drugs to Seniors

5% of this provider’s 4,561 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 8%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $40 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 3.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
OXYCODONE-ACETAMINOPHEN 2,276 907 S2 10 1 2
GABAPENTIN 1,050 422 2 6
FENTANYL 691 356 S2 3 17
LYRICA 675 231 10 4 14
CYMBALTA 648 278 5 20
AMITRIPTYLINE HCL 574 141 R 6 23
HYDROCODONE-ACETAMINOPHEN 530 212 S3 7 1
TIZANIDINE HCL 458 66 8 19
MELOXICAM 421 152 9 4
MORPHINE SULFATE ER 398 149 S2 10 18
ZOLPIDEM TARTRATE 320 108 11 33
OPANA ER 293 75 S2 12 32
DICLOFENAC SODIUM 252 49 13 5
CELEBREX 246 95 14 9
TOPIRAMATE 228 79 15 37
OXYCODONE HCL 197 50 S2 16 7
ENDOCET 190 53 S2 17 25
METHOCARBAMOL 162 55 R 18 34
METHADONE HCL 161 35 S2 19 21
FLUOXETINE HCL 128 15 20 46
TRAZODONE HCL 122 45 21 47
NORTRIPTYLINE HCL 115 50 22 48
POLYETHYLENE GLYCOL 3350 108 60 23 50
SEROQUEL XR 107 18 24 51
LUNESTA 100 40 25 53
HYDROCHLOROTHIAZIDE 100 40 25 53
SERTRALINE HCL 98 30 27 55
NUCYNTA 90 20 S2 28 57
ZOLPIDEM TARTRATE ER 89 27 29 58
PAROXETINE HCL 85 33 30 59
SAVELLA 79 0 31 60
CITALOPRAM HBR 75 40 32 62
QUETIAPINE FUMARATE 74 19 33 63
KADIAN 72 0 S2 34 64
TRAMADOL HCL 70 42 35 3
METHYLPREDNISOLONE 68 33 36 12
LIDODERM 64 31 37 69
VOLTAREN 61 31 38 36
BUTRANS 59 12 S3 39 73
OXYCONTIN 57 46 S2 40 13
TRAMADOL HCL-ACETAMINOPHEN 55 41 41 24
NEXIUM 51 18 42 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.